• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转甲状腺素蛋白心脏淀粉样变性患者中晚期心房传导阻滞的患病率及其与左心房功能的关系。

The Prevalence of Advanced Interatrial Block and Its Relationship to Left Atrial Function in Patients with Transthyretin Cardiac Amyloidosis.

作者信息

Lindow Thomas, Lindqvist Per

机构信息

Kolling Institute, Royal North Shore Hospital, University of Sydney, Sydney, NSW 2065, Australia.

Department of Clinical Physiology, Research and Development, Växjö Central Hospital, Region Kronoberg, 351 88 Växjö, Sweden.

出版信息

J Clin Med. 2021 Jun 23;10(13):2764. doi: 10.3390/jcm10132764.

DOI:10.3390/jcm10132764
PMID:34201866
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8267751/
Abstract

BACKGROUND

Advanced interatrial block (aIAB), which is associated with incident atrial fibrillation and stroke, occurs in the setting of blocked interatrial conduction. Atrial amyloid deposition could be a possible substrate for reduced interatrial conduction, but the prevalence of aIAB in patients with transthyretin cardiac amyloidosis (ATTR-CA) is unknown. We aimed to describe the prevalence of aIAB and its relationship to left atrial function in patients with ATTR-CA in comparison to patients with HF and left ventricular hypertrophy but no CA.

METHODS

The presence of aIAB was investigated among 75 patients (49 patients with ATTR-CA and 26 with HF but no CA). A comprehensive echocardiographic investigation was performed in all patients, including left atrial strain and strain rate measurements.

RESULTS

Among patients with ATTR-CA, 27% had aIAB and in patients with HF but no CA, this figure was 21%, ( = 0.78). The presence of aIAB was associated with a low strain rate during atrial contraction (<0.91 s) (OR: 5.2 (1.4-19.9)), even after adjusting for age and LAVi (OR: 4.5 (1.0-19.19)).

CONCLUSIONS

Advanced interatrial block is common among patients with ATTR-CA, as well as in patients with heart failure and left ventricular hypertrophy but no CA. aIAB is associated with reduced left atrial contractile function.

摘要

背景

晚期心房阻滞(aIAB)与房颤和中风的发生有关,发生于心房传导阻滞的情况下。心房淀粉样变沉积可能是心房传导减弱的一个潜在原因,但转甲状腺素蛋白心脏淀粉样变(ATTR-CA)患者中aIAB的患病率尚不清楚。我们旨在描述ATTR-CA患者中aIAB的患病率及其与左心房功能的关系,并与心力衰竭和左心室肥厚但无淀粉样变的患者进行比较。

方法

在75例患者(49例ATTR-CA患者和26例心力衰竭但无淀粉样变患者)中调查aIAB的存在情况。对所有患者进行了全面的超声心动图检查,包括左心房应变和应变率测量。

结果

在ATTR-CA患者中,27%有aIAB,在心力衰竭但无淀粉样变的患者中,这一数字为21%(P = 0.78)。即使在调整年龄和左心房容积指数后,aIAB的存在仍与心房收缩期低应变率(<0.91 s)相关(OR:5.2(1.4-19.9))(OR:4.5(1.0-19.19))。

结论

晚期心房阻滞在ATTR-CA患者以及心力衰竭和左心室肥厚但无淀粉样变的患者中很常见。aIAB与左心房收缩功能降低有关。

相似文献

1
The Prevalence of Advanced Interatrial Block and Its Relationship to Left Atrial Function in Patients with Transthyretin Cardiac Amyloidosis.转甲状腺素蛋白心脏淀粉样变性患者中晚期心房传导阻滞的患病率及其与左心房功能的关系。
J Clin Med. 2021 Jun 23;10(13):2764. doi: 10.3390/jcm10132764.
2
Differential characteristics of the typical and atypical advanced interatrial block.典型和非典型的晚期房间隔阻滞的差异特征。
Arch Cardiol Mex. 2020;90(3):266-273. doi: 10.24875/ACM.20000240.
3
New-onset atrial fibrillation after cavotricuspid isthmus ablation: identification of advanced interatrial block is key.三尖瓣峡部消融术后新发心房颤动:高级房内阻滞的识别是关键。
Europace. 2015 Aug;17(8):1289-93. doi: 10.1093/europace/euu379. Epub 2015 Feb 10.
4
Clinical features and predictors of atrial fibrillation in patients with light-chain or transthyretin cardiac amyloidosis.轻链或转甲状腺素蛋白心脏淀粉样变患者心房颤动的临床特征和预测因素。
ESC Heart Fail. 2022 Jun;9(3):1740-1748. doi: 10.1002/ehf2.13851. Epub 2022 Feb 17.
5
Multi-chamber speckle tracking imaging and diagnostic value of left atrial strain in cardiac amyloidosis.多腔室斑点追踪成像及左心房应变对心脏淀粉样变的诊断价值。
Eur Heart J Cardiovasc Imaging. 2022 Dec 19;24(1):130-141. doi: 10.1093/ehjci/jeac057.
6
Association between advanced interatrial block and small vessel diseases in the brain.晚期心房传导阻滞与脑小血管疾病之间的关联。
Quant Imaging Med Surg. 2020 Mar;10(3):585-591. doi: 10.21037/qims.2020.02.02.
7
Diagnostic and prognostic value of the left atrial myopathy evaluation in cardiac amyloidosis using echocardiography.超声心动图评估左心房心肌病在心脏淀粉样变性中的诊断和预后价值
ESC Heart Fail. 2024 Dec;11(6):4139-4147. doi: 10.1002/ehf2.15013. Epub 2024 Aug 11.
8
Atrial Fibrillation in Transthyretin Cardiac Amyloidosis: Predictors, Prevalence, and Efficacy of Rhythm Control Strategies.转甲状腺素蛋白心脏淀粉样变相关性心房颤动:节律控制策略的预测因素、发生率和疗效。
JACC Clin Electrophysiol. 2020 Sep;6(9):1118-1127. doi: 10.1016/j.jacep.2020.04.019. Epub 2020 Jul 29.
9
Restrictive Atrial Dysfunction in Cardiac Amyloidosis: Differences between Immunoglobulin Light Chain and Transthyretin Cardiac Amyloidosis Patients.心脏淀粉样变中的限制性心房功能障碍:免疫球蛋白轻链型与转甲状腺素蛋白型心脏淀粉样变患者的差异
Biomedicines. 2022 Jul 22;10(8):1768. doi: 10.3390/biomedicines10081768.
10
Prognosis of Transthyretin Cardiac Amyloidosis Without Heart Failure Symptoms.无心力衰竭症状的转甲状腺素蛋白心脏淀粉样变的预后
JACC CardioOncol. 2022 Nov 15;4(4):442-454. doi: 10.1016/j.jaccao.2022.07.007. eCollection 2022 Nov.

引用本文的文献

1
Advanced electrocardiography heart age: a prognostic, explainable machine learning approach applicable to sinus and non-sinus rhythms.高级心电图心脏年龄:一种适用于窦性和非窦性心律的预后性、可解释的机器学习方法。
Eur Heart J Digit Health. 2024 Oct 9;6(1):45-54. doi: 10.1093/ehjdh/ztae075. eCollection 2025 Jan.
2
Management of Arrhythmias and Conduction Disorders in Amyloid Cardiomyopathy.淀粉样心肌病心律失常和传导障碍的管理
J Clin Med. 2024 May 24;13(11):3088. doi: 10.3390/jcm13113088.
3
Arrhythmias in Patients with Cardiac Amyloidosis: A Comprehensive Review on Clinical Management and Devices.

本文引用的文献

1
Prevalence of Atrial Fibrillation and Thromboembolic Risk in Wild-Type Transthyretin Amyloid Cardiomyopathy.野生型转甲状腺素蛋白淀粉样心肌病中心房颤动的患病率及血栓栓塞风险
Circulation. 2021 Mar 30;143(13):1335-1337. doi: 10.1161/CIRCULATIONAHA.120.052136. Epub 2021 Mar 29.
2
The prevalence of TTR cardiac amyloidosis among patients undergoing bone scintigraphy.在接受骨闪烁显像的患者中,TTR 心脏淀粉样变性的患病率。
J Nucl Cardiol. 2021 Jun;28(3):825-830. doi: 10.1007/s12350-021-02575-0. Epub 2021 Mar 16.
3
Prevalence of wild type transtyrethin cardiac amyloidosis in a heart failure clinic.
心脏淀粉样变性患者的心律失常:临床管理与器械的综合综述
J Cardiovasc Dev Dis. 2023 Aug 5;10(8):337. doi: 10.3390/jcdd10080337.
4
Arrhythmic Manifestations of Cardiac Amyloidosis: Challenges in Risk Stratification and Clinical Management.心脏淀粉样变性的心律失常表现:风险分层与临床管理中的挑战
J Clin Med. 2023 Mar 29;12(7):2581. doi: 10.3390/jcm12072581.
5
Heart age estimated using explainable advanced electrocardiography.使用可解释的先进心电图技术评估心脏年龄。
Sci Rep. 2022 Jun 14;12(1):9840. doi: 10.1038/s41598-022-13912-9.
心力衰竭门诊中野生型转甲状腺素蛋白心脏淀粉样变性的患病率。
ESC Heart Fail. 2021 Feb;8(1):745-749. doi: 10.1002/ehf2.13110. Epub 2020 Nov 17.
4
Prevalence and Outcomes of Concomitant Aortic Stenosis and Cardiac Amyloidosis.并存的主动脉瓣狭窄和心脏淀粉样变性的患病率和结局。
J Am Coll Cardiol. 2021 Jan 19;77(2):128-139. doi: 10.1016/j.jacc.2020.11.006. Epub 2020 Nov 9.
5
Baseline ECG and Prognosis After Transcatheter Aortic Valve Implantation: The Role of Interatrial Block.经导管主动脉瓣植入术后的基础心电图与预后:房间隔阻滞的作用。
J Am Heart Assoc. 2020 Nov 17;9(22):e017624. doi: 10.1161/JAHA.120.017624. Epub 2020 Nov 3.
6
Atrial Fibrillation in Transthyretin Cardiac Amyloidosis: Predictors, Prevalence, and Efficacy of Rhythm Control Strategies.转甲状腺素蛋白心脏淀粉样变相关性心房颤动:节律控制策略的预测因素、发生率和疗效。
JACC Clin Electrophysiol. 2020 Sep;6(9):1118-1127. doi: 10.1016/j.jacep.2020.04.019. Epub 2020 Jul 29.
7
Relation of Advanced Interatrial Block to Risk of Atrial Fibrillation and Stroke.房内阻滞与心房颤动和中风风险的关系。
Am J Cardiol. 2020 Jun 1;125(11):1745-1748. doi: 10.1016/j.amjcard.2020.02.034. Epub 2020 Mar 16.
8
Interatrial blocks prevalence and risk factors for human immunodeficiency virus-infected persons.房间隔阻滞在人类免疫缺陷病毒感染者中的发生率和危险因素。
PLoS One. 2019 Oct 17;14(10):e0223777. doi: 10.1371/journal.pone.0223777. eCollection 2019.
9
Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis.专家共识建议:疑似转甲状腺素蛋白心脏淀粉样变性的诊断。
Circ Heart Fail. 2019 Sep;12(9):e006075. doi: 10.1161/CIRCHEARTFAILURE.119.006075. Epub 2019 Sep 4.
10
Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review.转甲状腺素蛋白淀粉样心肌病:美国心脏病学会最新临床综述
J Am Coll Cardiol. 2019 Jun 11;73(22):2872-2891. doi: 10.1016/j.jacc.2019.04.003.